Variant report
Variant | nsv948023 |
---|---|
Chromosome Location | chr10:57549072-57570724 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs533166102 | chr10:57556840-57556841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs530070061 | chr10:57556864-57556865 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs546687515 | chr10:57556876-57556877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs566381891 | chr10:57556889-57556890 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs551572707 | chr10:57556901-57556902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs376984073 | chr10:57556903-57556904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs74679557 | chr10:57556928-57556929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551939127 | chr10:57556971-57556972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184254696 | chr10:57556991-57556992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs11005028 | chr10:57557004-57557005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568741417 | chr10:57557016-57557017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537667027 | chr10:57557017-57557018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs537375062 | chr10:57557049-57557050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs554617793 | chr10:57557050-57557051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs568075086 | chr10:57557067-57557068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs533737698 | chr10:57557074-57557075 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189603329 | chr10:57557097-57557098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs573566596 | chr10:57557099-57557100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs9415357 | chr10:57557126-57557127 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs559171179 | chr10:57557185-57557186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs375141979 | chr10:57557240-57557241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143230586 | chr10:57557269-57557270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181153407 | chr10:57557274-57557275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561393521 | chr10:57557297-57557298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs574839022 | chr10:57557300-57557301 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567710073 | chr10:57557354-57557355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200239673 | chr10:57557391-57557392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs371630700 | chr10:57557425-57557426 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540617532 | chr10:57557427-57557428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs185954651 | chr10:57557430-57557431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532253528 | chr10:57557455-57557456 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552025185 | chr10:57557473-57557474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562458351 | chr10:57557518-57557519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs72024137 | chr10:57557534-57557535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189050197 | chr10:57557566-57557567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs548090130 | chr10:57557590-57557591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181486484 | chr10:57557596-57557597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186434485 | chr10:57557598-57557599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1916488 | chr10:57557624-57557625 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs571048993 | chr10:57557650-57557651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs551485068 | chr10:57557654-57557655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs141385865 | chr10:57557658-57557659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs539975017 | chr10:57557698-57557699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1916487 | chr10:57557708-57557709 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs575856925 | chr10:57557716-57557717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1916486 | chr10:57557717-57557718 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs1916485 | chr10:57557721-57557722 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs1916484 | chr10:57557743-57557744 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs114224520 | chr10:57557873-57557874 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141084467 | chr10:57557941-57557942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
small cell lung cancer | 17426248 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:57556800-57557800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr10:57557000-57557200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
3 | chr10:57557000-57557800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr10:57557200-57558000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
5 | chr10:57557800-57558000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
6 | chr10:57559400-57559600 | Enhancers | Fetal Brain Male | brain |
7 | chr10:57559600-57560400 | Weak transcription | Fetal Brain Male | brain |
8 | chr10:57559800-57560200 | Enhancers | Liver | Liver |
9 | chr10:57560200-57560600 | Flanking Active TSS | Liver | Liver |
10 | chr10:57560200-57560800 | Enhancers | Fetal Brain Female | brain |
11 | chr10:57560400-57561200 | Enhancers | Fetal Brain Male | brain |
12 | chr10:57560600-57561200 | Active TSS | Liver | Liver |
13 | chr10:57561200-57562000 | Enhancers | Liver | Liver |
14 | chr10:57561200-57570200 | Weak transcription | Fetal Brain Male | brain |
15 | chr10:57570200-57570400 | Enhancers | Fetal Brain Male | brain |